Some pharmaceutical companies offer copay assistance programs to make expensive medications more affordable, ensuring access to essential treatments and improving health outcomes. These programs reduce financial stress, help navigate insurance gaps, and prevent difficult trade-offs between medications and other essential expenses. By providing financial relief, they support medication adherence and overall well-being. 

 

However, there are also limitations on these programs.  Limitations of copay assistance programs include strict eligibility criteria, temporary support, limited medication coverage, administrative burdens, and potential impacts on insurance premiums. They can be complex to apply for and may not address the root issue of high drug prices, serving as only a temporary solution.